Consolidated Statements of Operations - USD ($)	3 Months Ended		6 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2022	Dec. 31, 2021
REVENUES
Product revenue, net	$ 1,026,416	$ 72,140	$ 1,896,070	$ 231,622
License and contract	0	250,000	0	250,000
Total revenues	1,026,416	322,140	1,896,070	481,622
OPERATING EXPENSES
Cost of products sold	98,707	29,171	185,203	83,104
Research and development	4,367,538	5,426,397	10,394,569	8,911,161
Selling, general and administrative	3,174,344	3,317,760	6,683,142	7,154,302
Gain on purchase commitment	(1,027,322)	0	(1,027,322)	0
Total operating expenses	6,613,267	8,773,328	16,235,592	16,148,567
Loss from operations	(5,586,851)	(8,451,188)	(14,339,522)	(15,666,945)
OTHER INCOME (EXPENSE)
Investment income	186,473	1,563	274,962	2,973
Foreign currency loss	(693,231)	(234,078)	(274,855)	(126,719)
Interest expense	(5,487)	(2,773)	(15,089)	(8,404)
Total other income (expense), net	(512,245)	(235,288)	(14,982)	(132,150)
Loss before income taxes	(6,099,096)	(8,686,476)	(14,354,504)	(15,799,095)
Income tax benefit	4,674,999	0	4,674,999	0
NET LOSS	$ (1,424,097)	$ (8,686,476)	$ (9,679,505)	$ (15,799,095)
Basic and diluted net loss per common share	$ (0.13)	$ (0.91)	$ (0.95)	$ (1.66)
Weighted average number of common shares outstanding used in computing basic and diluted net loss per common share (Note 1)	$ 10,802,863	$ 9,531,071	$ 10,215,616	$ 9,530,252